LEADER 02309oam  2200457Ia 450 
001 9910697570803321
005 20080915165423.0
035   $a(CKB)5470000002389243
035   $a(OCoLC)181643937
035   $a(EXLCZ)995470000002389243
100   $a20071120d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004$b[electronic resource] /$fMarie N. Stagnitti
210  1$a[Rockville, Md.] :$cMedical Expenditure Panel Survey, Agency for Healthcare Research and Quality,$d[2007]
215   $a4 unnumbered pages $cillustrations, tables
225 1 $aStatistical brief ;$v#186
300   $aTitle from title screen (viewed Sept. 15, 2008).
300   $a"September 2007."
300   $a"The estimates in this brief are derived from the Household Component of the 2004 Medical Expenditure Panel Survey (MEPS-HC)"--P. [1].
320   $aIncludes bibliographical references (page [4]).
330   $aThis statistical brief provides information on the top five outpatient prescription medicines ranked by total expenditures and insurance status for the Medicare population, as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2004. This brief also provides information on average total payments and average out-of-pocket payments per purchase for the top five drugs for Medicare beneficiaries, by insurance status.
606   $aMedicare
606   $aPharmaceutical services insurance$zUnited States
606   $aPrescription pricing$zUnited States
615  0$aMedicare.
615  0$aPharmaceutical services insurance
615  0$aPrescription pricing
700   $aStagnitti$b Marie N$01386624
712 02$aUnited States.$bAgency for Healthcare Research and Quality.
712 02$aMedical Expenditure Panel Survey (U.S.)
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697570803321
996   $aThe top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004$93516348
997   $aUNINA